Skip to evidence report

GRNLSA.p53_damage: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 297 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for GRNLSA.p53_damage
#Trait / studyIndividual trait IDMean IC score
1ALDH1A1/SORD ratioGCST90313248124.88
2Polycystic ovarian syndromeFING00001182104.57
3Phospholipids to total lipids ratio in chylomicrons and extremely large VLDLGCST9009304997.93
4Open wound of foot except toe(s) alone (PheCode 871.3)GCST9047628687.49
5Cryptic phenotype that captures alpha-1-antitrypsin deficiency severityGCST9010182582.01
6Treatment or medication use - rosuvastatin (UKB data field 20003_1141192410)GCST9004253976.16
7Job involves shift work | EmploymentUKBB0000038564.92
8EHMT2 levelsGCST9024144262.71
9Triglycerides to total lipids in medium LDL percentage (UKB data field 23623)GCST9026972059.59
10Right hippocampal volumeGCST9026797459.52
11MOG/PTPRN2 ratioGCST9031547559.07
12DNAJA2/FIS1 ratioGCST9031450158.27
13Free cholesterol to total lipids in large VLDL percentage (UKB data field 23592)GCST9026968958.26
14CD83/TREM2 ratioGCST9031390857.06
15Saturated fatty acids to total fatty acids percentageGCST9050219956.48
16Linoleic acid levelsGCST9049830656.33
17Smoking status - Previous | SmokingUKBB0000078155.72
18NADK/S100A11 ratioGCST9031551354.18
19Phospholipids to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23579)GCST9026967654.17
20Linoleic acid to total fatty acids percentageGCST9050232153.90
21Triglycerides to total lipids in large LDL percentage (UKB data field 23618)GCST9026971553.38
22AXIN1/CLIP2 ratioGCST9031340453.35
23Raw carrot likingGCST9009481852.49
24Triglycerides in large VLDLGCST9049828052.45
25T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 80)GCST9032064352.38
26Phospholipids to total lipids in very small VLDL percentage (UKB data field 23604)GCST9026970152.19
27ITGB1/SELP ratioGCST9031523051.54
28COL4A1 levelsGCST9046881851.39
29Phospholipids to total lipids ratio in very large HDLGCST9009301351.22
305,6-dihydrouridine levelsGCST9019976750.98
31Triglyceride levelsGCST9027864550.74
32Cholesteryl esters to total lipids in small VLDL percentage (UKB data field 23601)GCST9026969850.65
33Linoleic acid to total fatty acids percentage (UKB data field 23456)GCST9026955350.62
34Cholesterol in Large VLDLGCST9049812350.29
35Saturated fatty acids to total fatty acids percentageGCST9050220549.72
36Cholesterol to total lipids in large VLDL percentage (UKB data field 23590)GCST9026968749.20
37Phospholipids to total lipids in large LDL percentage (UKB data field 23614)GCST9026971147.96
38NCK2/PLA2G4A ratioGCST9031552447.75
39Polyunsaturated fatty acids to saturated fatty acids ratioGCST9050216047.68
403,4-dihydroxybutyrate levelsGCST9019981647.51
41Triglycerides to total lipids in very large VLDL percentage (UKB data field 23588)GCST9026968547.34
42GRP levelsGCST9024124247.06
43PGLYRP2 levelsGCST9047022046.59
44Ratio of linoleic acid to total fatty acidsGCST9009288146.37
45Triglycerides to total lipids in IDL percentage (UKB data field 23613)GCST9026971046.34
46LGALS8/VWF ratioGCST9031532246.29
47Right-hemisphere salience/ventral attention network to putamen white-matter structural connectivityGCST9030281946.12
48Cholesterol to total lipids in IDL percentage (UKB data field 23610)GCST9026970746.06
49Cholesteryl esters to total lipids in very large VLDL percentage (UKB data field 23586)GCST9026968345.56
50BTD levelsGCST9046847745.48
51C9 Carnitine levels in chronic kidney diseaseGCST9025768245.11
52Linoleic acid to total fatty acids percentageGCST9050201745.01
53Triglycerides to total lipids in small LDL percentage (UKB data field 23628)GCST9026972544.94
54Degree of unsaturationGCST9050274844.81
55Cholesteryl Esters in Large VLDLGCST9049815444.64
56Saturated fatty acids to total fatty acids percentageGCST9050268544.28
57PCDH17/ROBO1 ratioGCST9031560444.25
58Triglycerides to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23583)GCST9026968044.07
59Cholesteryl esters to total lipids in IDL percentage (UKB data field 23611)GCST9026970843.56
60PLXDC2 levelsGCST9047026443.47
61Ovarian dysfunctionFING0000113343.35
62Cholesteryl Esters in Small HDLGCST9049938643.15
63Triglycerides to total lipids ratio in chylomicrons and extremely large VLDLGCST9009305143.11
64DAB2/FKBP5 ratioGCST9031436343.10
65AXIN1/DOK2 ratioGCST9031340643.07
66IDP dMRI ProbtrackX FA cst rGCST9000393443.03
67Phospholipids to total lipids in very large HDL percentage (UKB data field 23629)GCST9026972642.48
68Cholesteryl ester levels in small HDLGCST9009294642.21
69APP/CCL28 ratioGCST9031331741.79
70Polyunsaturated fatty acids to saturated fatty acids ratioGCST9050258141.70
71Phospholipids in small HDLGCST9049948341.64
72IDP dMRI TBSS L2 Posterior limb of internal capsule RGCST9000414141.46
73Cholesteryl esters to total lipids in large VLDL percentage (UKB data field 23591)GCST9026968841.39
74Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDLGCST9009304541.38
75GPIHBP1 levelsGCST9046939041.31
76BMP4 levelsGCST9046845341.29
77IL31RA levelsGCST9046958940.60
78CNTN1/EGFR ratioGCST9031416240.46
79GFER/TRIAP1 ratioGCST9031492140.16
80PRCP/SELE ratioGCST9031572639.90
81SIRPA levelsGCST9047063939.81
82Triglycerides in very large VLDLGCST9050068039.70
83Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)GCST9026968439.60
84Free cholesterol in very large HDLGCST9050038039.58
85Omega-6 fatty acid levelsGCST9050210039.53
86Free cholesterol levels in chylomicrons and extremely large VLDLGCST9050096539.45
87Linoleic acid levelsGCST9049830938.84
88PCDH17 levelsGCST9047016938.82
89Osteoarthritis; localized | musculoskeletalUKBB0000059538.75
90Cholesterol levels in very large HDLGCST9050031038.46
91Main speciality of consultant (recoded) - Gastroenterology | Summary AdministrationUKBB0000041538.23
92Phospholipids to total lipids ratio in medium LDLGCST9009291338.20
93HippSubfield lh volume hippocampal-fissureGCST9000267238.04
94CRELD2/HYOU1 ratioGCST9031425538.03
95Phospholipids to total lipids ratio in large LDLGCST9009286538.00
96DAB2/TBL1X ratioGCST9031436837.91
97Cholesterol levels in chylomicrons and extremely large VLDLGCST9050090537.72
98Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)GCST9026968237.57
99Free cholesterol in medium VLDLGCST9049896537.46
100Phosphatidylglycerol (34:1) levelsGCST9002506137.45
101Chronic ulcer of leg or foot (PheCode 707.2)GCST9047621837.18
102CNTN1 levelsGCST9046880337.06
103Cholesterol in Small HDLGCST9049935837.01
104Phospholipids in medium VLDLGCST9049902436.60
105Cholesterol to total lipids in small HDL percentage (UKB data field 23645)GCST9026974236.48
106N-delta-acetylornithine levelsGCST9020069136.43
107Phospholipids in HDLGCST9049743036.35
108Cholesteryl Esters in Large VLDLGCST9049814636.32
109DTI autoptx FA slf l tractGCST9038513336.05
110Linoleic acid to total fatty acids percentageGCST9050232035.97
111PLG levelsGCST9047025735.96
112Phospholipids to total lipids in medium VLDL percentage (UKB data field 23594)GCST9026969135.95
113Linoleic acid to total fatty acids percentageGCST9050233235.94
114Cholesteryl esters to total lipids in small HDL percentage (UKB data field 23646)GCST9026974335.93
115Dimethylglycine levelsGCST9020042435.88
116Average diameter for HDL particlesGCST9049745435.69
117IDP dMRI TBSS MO Posterior limb of internal capsule RGCST9000397035.58
118AXIN1/CDKN1A ratioGCST9031340335.57
119MPHOSPH8/PSRC1 ratioGCST9031547835.29
120Cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23580)GCST9026967735.25
121Acetate levels (UKB data field 23475)GCST9026957235.16
122Concentration of medium HDL particlesGCST9049861735.13
123Phospholipids to total lipids in large VLDL percentage (UKB data field 23589)GCST9026968635.09
124Cholesteryl esters to total lipids in very large HDL percentage (UKB data field 23631)GCST9026972835.03
125IDP dMRI ProbtrackX L2 cst rGCST9000428234.92
126Biological Grandparent (paternal): Coronary Artery / Coronary Heart DiseaseGCST9047554834.65
127Docosahexaenoic acid levelsGCST9050198434.55
128Phospholipids in HDLGCST9049743734.31
129Free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23582)GCST9026967934.18
130Docosahexaenoic acid levelsGCST9050224234.06
131Triglycerides in medium LDLGCST9049887034.00
132Total lipids in medium HDLGCST9049859733.99
133Omega-6 fatty acids to total fatty acids percentageGCST9050254033.99
134AXIN1/INPPL1 ratioGCST9031341033.92
135Phospholipids in very large HDLGCST9050045133.88
136Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050207533.87
137NCF2 levelsGCST9047000633.74
138Omega-3 fatty acid levelsGCST9050206233.69
139IDP dMRI ProbtrackX L3 cst rGCST9000430933.68
140Triglycerides to total lipids in large VLDL percentage (UKB data field 23593)GCST9026969033.65
141Phospholipids in large HDLGCST9049784733.43
142Free cholesterol in very large VLDLGCST9050057533.39
143Polyunsaturated fatty acids to saturated fatty acids ratioGCST9050216633.35
144CTSB levelsGCST9046890833.34
145SLC39A5 levelsGCST9047066133.32
146Free cholesterol in very large HDLGCST9050038333.26
147Ratio of docosahexaenoic acid to total fatty acid levelsGCST9009281733.12
148Free cholesterol to total lipids ratio in large VLDLGCST9009287333.09
149Cholesterol to total lipids ratio in large VLDLGCST9009286933.07
150OXT levelsGCST9047013933.03
151CRKL/PLA2G4A ratioGCST9031427132.91
152Other predominantly sexually transmitted diseases, not elsewhere classifiedFING0000108932.76
153Phospholipids in large LDLGCST9049804932.74
154Phospholipids to Total Lipids in Medium HDL percentageGCST9049865132.57
155Free Cholesterol to Total Lipids in Medium HDL percentageGCST9049858032.54
156Free cholesterol in very large VLDLGCST9050058132.52
157Cholesterol_[M+H-H2O]1+ levelsGCST9006013332.51
158CLEC4G/SEMA3F ratioGCST9031412332.44
159ERBB2/FURIN ratioGCST9031468632.41
160Free Cholesterol to Total Lipids in Medium HDL percentageGCST9049858332.40
161Saturated fatty acids levelsGCST9049995032.39
162Phospholipids to Total Lipids in Medium HDL percentageGCST9049865332.29
163Polyunsaturated fatty acids to total fatty acids percentageGCST9050264432.05
164ING1 levelsGCST9046961332.03
165Polyunsaturated fatty acids to total fatty acids percentage (UKB data field 23453)GCST9026955031.91
166Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)GCST9026954931.90
167BCAN/NCAN ratioGCST9031348131.79
168Cholesterol to total lipids in small VLDL percentage (UKB data field 23600)GCST9026969731.77
169Fasting blood glucoseGCST00056831.71
170PLTP levelsGCST9047026231.69
171Triglycerides to total lipids ratio in medium LDLGCST9009291531.62
172Polyunsaturated fatty acids to saturated fatty acids ratioGCST9050259231.24
173AMBP/EFEMP1 ratioGCST9031325331.12
174Triglycerides in very large VLDLGCST9050067131.03
175Phospholipids to total lipids in small HDL percentage (UKB data field 23644)GCST9026974130.85
176Cholesteryl Esters in Small VLDLGCST9049978230.84
177Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST9050094330.61
178Phospholipid levels in chylomicrons and extremely large VLDLGCST9050104230.51
179Omega-6 fatty acids to total fatty acids percentageGCST9050212130.50
180ITGAV levelsGCST9046963930.40
181APOA1 levelsGCST9049711930.35
182DTI TBSS FA Superior longitudinal fasciculus LGCST9038442130.24
183aparc-pial rh area lateraloccipitalGCST9000318430.21
184Acetate levelsGCST9009280330.08
185Fasting plasma glucoseGCST9029778730.07
186Ratio of saturated fatty acids to total fatty acidsGCST9009298130.01
187Triglycerides in medium VLDLGCST9049906529.91
188Cholesterol in Medium VLDLGCST9049890329.87
189Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)GCST9026972429.79
190ENG/PEAR1 ratioGCST9031464929.68
191Free cholesterol to total lipids in medium VLDL percentage (UKB data field 23597)GCST9026969429.65
192AXIN1/MAP2K6 ratioGCST9031341329.58
193Phospholipids in small HDLGCST9049947829.58
194APOM/MCAM ratioGCST9031331529.57
195DTI autoptx FA slf r tractGCST9038513429.41
196Cholesterol to total lipids ratio in chylomicrons and extremely large VLDLGCST9009304129.40
197Total lipids in medium HDLGCST9049860429.39
198Estradiol levelsGCST9001210529.34
199Past tobacco smoking | SmokingUKBB0000063529.31
200Concentration of medium HDL particlesGCST9049862229.29
201AXIN1/CALCOCO1 ratioGCST9031340229.10
202Tiglylcarnitine (C5:1-DC) levelsGCST9019980029.09
203Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)GCST9026970229.00
204Free cholesterol in very small VLDLGCST9050077429.00
205CLU levelsGCST9046879328.98
206NCR1 levelsGCST9009015328.94
207Cholesterol levels in very large HDLGCST9050032228.93
208MXRA8 levelsGCST9046996828.90
209Free cholesterol in IDLGCST9049756128.87
210Triglycerides to total lipids in small VLDL percentage (UKB data field 23603)GCST9026970028.83
211Cholesterol in Large VLDLGCST9049811928.71
212Total Lipids in HDLGCST9049740128.66
213Free cholesterol to total lipids ratio in very large VLDLGCST9009302128.66
214Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)GCST9026970528.61
215Phospholipids to total lipids ratio in very small VLDLGCST9009303728.61
216Phosphatidylinositol (20:0_20:4) levelsGCST9002508328.50
217Saturated fatty acids to total fatty acids percentageGCST9050269628.46
218Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)GCST9026969928.33
219Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050239928.25
220Linoleic acid levelsGCST9050200928.23
221NRP1 levelsGCST9047008528.17
222Phospholipids to Total Lipids in Very Large HDL percentageGCST9050047428.09
223Type 2 diabetesGCST9046815127.95
224Phospholipid levels in very large HDLGCST9009301227.87
225CKAP4/IL4R ratioGCST9031407227.84
226FST levelsGCST9001208027.81
227Docosahexaenoic acid levelsGCST9050225427.78
228Fresh fruit consumptionGCST9013297927.69
229Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)GCST9026970327.60
230PDCD5 levelsGCST9047018227.57
231Cholesteryl Esters in Medium VLDLGCST9049893927.52
232TNC/VCAM1 ratioGCST9031592727.49
233IDP dMRI TBSS MO Posterior limb of internal capsule LGCST9000397127.32
234Triglycerides to total lipids in medium VLDL percentage (UKB data field 23598)GCST9026969527.29
235CLEC1A/GPR37 ratioGCST9031408427.26
236Phospholipids in medium VLDLGCST9049902527.25
237Phospholipids in very large HDLGCST9050045827.23
238CLEC4A levelsGCST9046877127.14
239Free cholesterol in medium VLDLGCST9049896027.09
240Total Lipids in HDLGCST9049739327.00
241Total lipids in very large HDLGCST9050041026.99
242Cholesteryl Esters to Total Lipids in Large HDL percentageGCST9049776326.98
243APOA1 levelsGCST9049712226.94
244Triglycerides in medium LDLGCST9049886426.93
245ECE1 levelsGCST9046906126.90
246IDP dMRI TBSS L2 Posterior limb of internal capsule LGCST9000414226.89
247CDON levelsGCST9046868726.89
248FADD/NCK2 ratioGCST9031477026.77
249Phospholipid levels in chylomicrons and extremely large VLDLGCST9050103126.64
250Docosahexaenoic acid levelsGCST9050197826.64
251LGALS1/LGALS8 ratioGCST9031531426.64
252IL1R2 levelsGCST9046957226.45
253LTBP2/PDGFRA ratioGCST9031533826.45
254EGFR/FAP ratioGCST9031461326.41
255Phospholipids to Total Lipids in Large HDL percentageGCST9049786326.38
256PLAUR/TREM2 ratioGCST9031567626.36
257SCARA5/TNC ratioGCST9031581026.33
258Cholesterol to Total Lipids in Medium HDL percentageGCST9049851926.28
259Free Cholesterol to Total Lipids in Large HDL percentageGCST9049779326.26
260Concentration of very large HDL particlesGCST9050043626.26
261Triglycerides to total lipids ratio in very large VLDLGCST9009302726.25
262Docosahexaenoic acid levels (UKB data field 23450)GCST9026954726.20
263Phosphoglycerides levelsGCST9049925926.19
264Cholesteryl esters to total lipids ratio in large VLDLGCST9009287126.17
265Average diameter for HDL particlesGCST9013270226.07
266Chronic hepatitis C infectionGCST9001858526.04
267Triglyceride levels in chylomicrons and extremely large VLDLGCST9050107526.03
268Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050241126.01
269LGALS3 levelsGCST9046976125.95
270Polyunsaturated fatty acids to total fatty acids percentageGCST9050217325.93
271PROC levelsGCST9047033525.89
272RAD23B levelsGCST9047041825.85
273CNPY4/STAT5B ratioGCST9031415525.77
274Cholesterol to Total Lipids in Large HDL percentageGCST9049773025.72
275FLT1/TGFB1 ratioGCST9031485725.63
276DKKL1 levelsGCST9046900025.57
277F9/PROC ratioGCST9031474825.57
278IritisGCST9001865125.53
279LRP1 levelsGCST9046979725.53
280Triglycerides in small LDLGCST9049971225.51
281ENG/TNFSF10 ratioGCST9031465125.51
282Cholesterol to total lipids ratio in very large HDLGCST9009300525.49
283Chronic ulcer of skin (PheCode 707)GCST9047621625.45
284OsteoarthritisGCST9047638325.42
285OtosclerosisFING0000113125.34
286Cholesteryl Esters in IDLGCST9049752325.27
287Cholesterol to total lipids in large LDL percentage (UKB data field 23615)GCST9026971225.26
288CLPP/DECR1 ratioGCST9031413725.24
289Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050256625.22
290Average diameter for HDL particlesGCST9009282825.14
291Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)GCST9026955525.12
292ERP44 levelsGCST9046915025.11
293TFRC levelsGCST9045168425.04
294ATXN10/CASP10 ratioGCST9031339625.02
295Triglycerides to total lipids ratio in large LDLGCST9009286725.00
296Average diameter for HDL particles (UKB data field 23433)GCST9026953024.92
297CC2D1A/STIP1 ratioGCST9031366524.91
298Omega-6 fatty acids to total fatty acids percentageGCST9050212724.86
299Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)GCST9026958424.85
300MFAP4 levelsGCST9046989824.84
301Lysophosphatidylethanolamine-P_20:0_[M-H]1- levelsGCST9006014724.79
302Free Cholesterol in HDLGCST9049738124.78
303Cholesterol in Small VLDLGCST9049974624.76
304Docosahexaenoic acid to total fatty acids percentageGCST9050228124.76
305Triglycerides in LDL (UKB data field 23409)GCST9026950624.73
306Concentration of HDL particlesGCST9049741424.72
307Cholesteryl esters to total lipids ratio in small VLDLGCST9009297124.72
308Cholesterol to Total Lipids in Very Large HDL percentageGCST9050032424.68
309DNAJB1/STIP1 ratioGCST9031451324.65
310Ratio of polyunsaturated fatty acids to total fatty acidsGCST9009294124.61
311Cholesteryl Esters to Total Lipids in Medium HDL percentageGCST9049855024.55
312Sleep apnea syndromeGCST9026736124.52
313Fasting blood insulinGCST00518524.48
314Cholesteryl Esters to Total Lipids in Very Large HDL percentageGCST9050035924.44
315LAT2/SERPINB1 ratioGCST9031527924.39
316NTRK2 levelsGCST9047009724.39
317IDP dMRI TBSS FA Superior cerebellar peduncle RGCST9000388924.38
318Cholesterol in Medium LDLGCST9049870324.38
319Cholesterol levels in small HDLGCST9009294424.31
320Arabitol/xylitol levelsGCST9020001124.18
321Triacylglycerol_56:5_[M+NH4]1+ levelsGCST9006055424.18
322Free cholesterol to total lipids ratio in very large HDLGCST9009300924.17
323HNRNPAB levelsGCST9008869324.16
324Total cholesterol levelsGCST9023967524.14
325Total lipids in large HDLGCST9049781524.11
326Triglycerides to Total Lipids in Large HDL percentageGCST9049789624.01
327Breast conditions, congenital or relating to hormones (PheCode 612)GCST9047616224.00
328AIFM1/PLXNA4 ratioGCST9031322023.99
329Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)GCST9026969223.98
330Phospholipids to total lipids in IDL percentage (UKB data field 23609)GCST9026970623.98
331Triglycerides to total lipids ratio in IDLGCST9009284223.97
332Omega-3 fatty acid levelsGCST9050205623.95
333Phospholipids to Total Lipids in Large HDL percentageGCST9049786823.95
334CHL1 levelsGCST9046874523.92
335MCAM levelsGCST9046987023.90
336Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T83ECGA00008323.90
337Blood cell traits latent factor 20 (red cell)GCST9055926223.89
338Polyunsaturated fatty acid levelsGCST9050213323.84
339CNDP1/EGFR ratioGCST9031414623.82
340Cholesterol to total lipids in small LDL percentage (UKB data field 23625)GCST9026972223.82
341Free cholesterol in large HDLGCST9049778623.80
342GRAP2/PTPN6 ratioGCST9031498623.80
343ITGA5/SELE ratioGCST9031520523.72
344SERPINF2 levelsGCST9047059923.67
345CCL28/PDGFB ratioGCST9031369523.67
346Osteoarthrosis | musculoskeletalUKBB0000059623.67
347Average diameter for VLDL particles (UKB data field 23431)GCST9026952823.66
348Concentration of large HDL particlesGCST9049782823.63
349Posterior thigh muscle volumeGCST9026735323.61
350Triglycerides to total lipids ratio in large VLDLGCST9009287923.59
351Phospholipids to total lipids ratio in IDLGCST9009284023.58
352Free Cholesterol in HDLGCST9049737923.54
353Metabolic syndromeGCST00960223.53
354Fresh fruit intake | DietUKBB0000027223.50
355Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T84ECGA00008423.48
356Concentration of very large HDL particlesGCST9050043123.47
357Glutamine levelsGCST9009281823.47
358Triglycerides in medium LDL (UKB data field 23543)GCST9026964023.47
359Phospholipids to total lipids ratio in medium VLDLGCST9009292523.41
360Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)GCST9026969623.36
361NAAA/SMPD1 ratioGCST9031551023.36
362Free cholesterol in small HDLGCST9049942523.30
363Cholesteryl Esters in Small VLDLGCST9049978623.30
364ENPP5 levelsGCST9046911623.28
365Polyunsaturated fatty acids to total fatty acids percentageGCST9050217923.26
366PDGFB/SPARC ratioGCST9031562823.24
367EREG/MPIG6B ratioGCST9031470423.23
368Concentration of small HDL particlesGCST9009295123.17
369Phospholipids in very small VLDLGCST9050084023.15
370Phospholipids in medium LDLGCST9049883123.13
371Cholesteryl Esters to Total Lipids in Very Small VLDL percentageGCST9050076423.09
372Triglycerides in small VLDLGCST9049991723.03
3731-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levelsGCST9020005723.00
374Lysophosphatidylcholine_16:1_[M+H]1+/Lysophosphatidylethanolamine_19:1_[M+H]1+ levelsGCST9006014823.00
375BCAM/PCDH17 ratioGCST9031347522.99
376HDL cholesterol levelsGCST9049735222.95
377Linoleic acid to total fatty acids percentageGCST9050202322.93
378Phospholipids to total lipids ratio in small HDLGCST9009295322.90
379Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050206922.89
380APOA levelsGCST9046806122.89
381Right molecular layer hippocampal volume (body)GCST9026797522.80
382Phospholipids to total lipids in medium LDL percentage (UKB data field 23619)GCST9026971622.74
383DTI autoptx FA fmi tractGCST9038512322.71
384Cholesterol in Small LDLGCST9049955922.65
385Cholesterol levels in very large VLDLGCST9050051722.55
386Total cholines levelsGCST9049718522.53
387DTI TBSS L3 Superior longitudinal fasciculus LGCST9038456522.52
388IDP dMRI ProbtrackX L2 cst lGCST9000428122.52
389high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed)GCST9047534822.52
390Triglycerides in large LDLGCST9049808322.51
391Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050239822.51
392Weight-to-muscle ratioGCST9026735922.46
393Free cholesterol in large HDLGCST9049778022.45
394Grapefruit likingGCST9009477422.43
395APOA levelsUKBB0000004022.40
396Cholesterol levels in very large VLDLGCST9050051822.36
397TIE1 levelsGCST9047086322.34
398PAPPA levelsGCST9047015722.33
399Total concentration of lipoprotein particlesGCST9050010122.32
400Average diameter for LDL particlesGCST9049845822.29
401Cholesterol in IDLGCST9049749522.27
402Cholesterol esters in very large HDLGCST9050034422.25
403Metabolic syndromeGCST9044448922.23
404Hippocampal subfield right CA1 volume (head)GCST9026796122.18
405CD99 levelsGCST9046865822.18
406Omega-6 fatty acids levelsGCST9049917722.13
407Cholesterol in Medium LDLGCST9049870722.11
408IFIT2 levelsGCST9009086422.06
409APBB1IP/NADK ratioGCST9031329822.03
410IDP dMRI TBSS ICVF Uncinate fasciculus LGCST9000437221.99
411Cholesteryl esters in very large VLDLGCST9050055221.97
412Cholesterol to total lipids in very large HDL percentage (UKB data field 23630)GCST9026972721.97
413CCL22 levelsGCST9024049021.90
414Docosahexaenoic acid to total fatty acids percentageGCST9050199721.88
415PRTG levelsGCST9047034721.85
416aseg global volume 3rd-VentricleGCST9000259921.77
417Free cholesterol in medium HDLGCST9049856221.73
418Free cholesterol in large VLDLGCST9049818121.70
419ADH4/DCXR ratioGCST9031319021.70
420Cholesteryl Esters in HDLGCST9049736821.65
421T1 FreeSurfer a2009s rh G&S subcentral volumeGCST9038504121.64
422Smoking status - Never | SmokingUKBB0000078021.63
423IDP dMRI TBSS L2 Anterior limb of internal capsule LGCST9000414021.60
424Hearing difficulty and hearing difficulty with background noiseGCST9024577621.59
425Average diameter for VLDL particlesGCST9050027921.57
426Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)GCST9026971421.56
427Mean diameter of VLDL particlesGCST9013273421.55
428IDP dMRI TBSS OD Posterior limb of internal capsule LGCST9000442121.54
429Peripheral vascular diseaseGCST9047521921.54
430Phosphatidylcholine levelsGCST9049924021.53
431Free cholesterol in large VLDLGCST9049818521.52
432Unspecified osteomyelitis (PheCode 710.19)GCST9047622421.48
433BAX levelsGCST9046842421.47
434ADAM23 levelsGCST9046821921.45
435Total lipid levels in very large HDLGCST9009301021.41
436Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632)GCST9026972921.40
437Phospholipids in small VLDLGCST9049988121.39
438Cholesterol to total lipids ratio in small HDLGCST9009294521.39
439Average diameter for LDL particles (UKB data field 23432)GCST9026952921.38
440KDR levelsGCST9046967221.36
441Glutamine levels (UKB data field 23461)GCST9026955821.30
442Monounsaturated fatty acids to total fatty acids percentageGCST9050238421.27
443Triglycerides in IDLGCST9049766121.25
444Docosahexaenoic acid to total fatty acids percentageGCST9049726821.23
4451-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levelsGCST9020033021.22
446STX8/USP8 ratioGCST9031589621.21
447Smoking status, ever vs never | Other measurementUKBB0000078221.21
448ISLR2 levelsGCST9046962921.21
449Omega-3 fatty acid levelsGCST9050243721.20
450Triglycerides in large LDLGCST9049807621.18
451Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)GCST9026969321.15
452PTPRM/SELE ratioGCST9031575321.13
453STK24/TDRKH ratioGCST9031589321.12
454N-acetylalanine levelsGCST9020030321.10
455Phospholipids in IDLGCST9049762821.07
456DTI autoptx MD ptr r tractGCST9038524021.06
457high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed)GCST9047535621.01
458DNAJB1/METAP2 ratioGCST9031450920.99
459Cholesterol to Total Lipids in Medium HDL percentageGCST9049851620.93
460NADK/PXN ratioGCST9031551220.91
461ANGPTL3/TFPI ratioGCST9031327020.83
462high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)GCST9047535220.80
463Total lipids in large HDLGCST9049781820.77
464Docosahexaenoic acid to total fatty acids percentageGCST9049727020.74
465Phospholipids in large VLDLGCST9049824720.72
466Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)GCST9026971920.68
467Average diameter for VLDL particlesGCST9009300220.67
468Free cholesterol levels in very large HDLGCST9013268020.64
469MAMDC2 levelsGCST9046984120.56
470Polyunsaturated fatty acids to saturated fatty acids ratioGCST9050258020.54
471Phospholipids in medium HDL (UKB data field 23567)GCST9026966420.50
472Red cell distribution width varianceGCST9056570520.47
473IDP dMRI TBSS L2 Uncinate fasciculus LGCST9000416820.43
474Free Cholesterol to Total Lipids in Very Large HDL percentageGCST9050039820.38
475ICD10 N84: Polyp of female genital tractGCST9045421620.37
476Docosahexaenoic acid to total fatty acids percentageGCST9050226820.35
477Degree of unsaturationGCST9050273620.33
478Triglycerides in large VLDLGCST9049826720.33
479Cholesteryl esters in very large VLDLGCST9050055620.32
480Free cholesterol in medium HDLGCST9049856320.26
481IDP dMRI ProbtrackX L3 cst lGCST9000430820.25
482BOC levelsGCST9046845820.22
483Cholesterol in IDLGCST9049750120.20
484Free cholesterol in small VLDLGCST9049980820.17
485RBP7 levelsGCST9047044020.17
486aparc-DKTatlas rh area lateraloccipitalGCST9000327420.12
487Free cholesterol to total lipids ratio in medium VLDLGCST9009292120.11
488FLRT2/GFRA3 ratioGCST9031485520.11
489CD200/CLEC4G ratioGCST9031374620.09
490SERPINA5 levelsGCST9047058520.08
491Phospholipids to Total Lipids in Very Large HDL percentageGCST9050047220.04
492DTI autoptx L3 slf l tractGCST9038521420.03
493Hypotaurine levelsGCST9020037920.02
494Cholesterol in Small HDLGCST9049934820.02
495Average diameter for HDL particlesGCST9049744619.98
496High-density lipoprotein levels (MTAG)GCST9017914719.96
497Ovarian cancer-related tumor marker CA 125 levelsGCST9001207819.95
498PTPN1/TDRKH ratioGCST9031574519.89
499ADAMTSL4 levelsGCST9046822919.89
500Free cholesterol levels in very large HDLGCST9009300819.88
501NUDT5/TXNRD1 ratioGCST9031558219.77
502SEMA3F levelsGCST9047057019.73
503T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64)GCST9032062719.69
504HAVCR2/TREM2 ratioGCST9031503119.66
505CDCP1/MSR1 ratioGCST9031393819.66
506PEAR1 levelsGCST9047020419.62
507Phospholipids in large HDL (UKB data field 23560)GCST9026965719.60
508Levulinate 4-oxovalerate levelsGCST9024354519.58
509aparc-a2009s lh volume S-centralGCST9000296919.56
510Phospholipids to total lipids ratio in large VLDLGCST9009287719.56
511Triglycerides in IDLGCST9049767119.55
512Cholesteryl esters in small HDL (UKB data field 23576)GCST9026967319.55
513BA-exvivo lh volume BA4pGCST9000284019.55
514MAPK9 levelsGCST9046985719.54
515Polyunsaturated fatty acids to total fatty acids percentageGCST9050263319.53
516Phospholipid levels in medium HDLGCST9009290019.53
517IDP dMRI ProbtrackX FA cst lGCST9000393319.51
518IDP dMRI TBSS ICVF Cerebral peduncle RGCST9000434119.50
519Docosahexaenoic acid to total fatty acids percentageGCST9050199119.47
520Cholesterol to Total Lipids in Very Small VLDL percentageGCST9050073119.44
521Concentration of medium HDL particles (UKB data field 23565)GCST9026966219.43
522Abdominal and pelvic pain | Symptoms and signs involving the digestive system and abdomenUKBB0000000119.43
523CRADD/DARS1 ratioGCST9031423419.40
524Substance dependenceGCST9001870419.39
525Concentration of HDL particlesGCST9049740619.36
526Free cholesterol in medium HDL (UKB data field 23570)GCST9026966719.34
527CDH6 levelsGCST9046867719.31
528Phospholipid levels in large HDLGCST9009285219.31
529APOA1 levelsGCST9026953719.30
530Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050109219.29
531Triglycerides in medium VLDLGCST9049906419.23
532Average diameter for LDL particlesGCST9049845719.22
533Sleep apnea | neurologicalUKBB0000077419.18
534COX5B levelsGCST9046883419.15
535NOTCH3 levelsGCST9047006719.10
536Docosahexaenoic acid to total fatty acids percentageGCST9050228019.09
537Degree of unsaturationGCST9050223119.08
538Cholesterol in Medium VLDLGCST9049890919.08
539Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levelsGCST9006025419.07
540Triglycerides in large LDL (UKB data field 23536)GCST9026963319.04
5413-hydroxydecanoate metabolite levelGCST9061547219.03
542PARK7 levelsGCST9047015919.01
543ARF6 levelsGCST9046834819.01
544DAPP1/PTPN6 ratioGCST9031439719.00
545Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T254ECGU00025418.98
546CLEC4G/MERTK ratioGCST9031412118.97
547Worry too long after embarrassment | Mental healthUKBB0000092218.95
548Triglycerides in IDL (UKB data field 23529)GCST9026962618.92
549Triglycerides to total lipids ratio in small LDLGCST9009296718.91
550Cholesteryl Esters to Total Lipids in Medium HDL percentageGCST9049855618.91
551STAB2 levelsGCST9047075518.90
552Concentration of large HDL particlesGCST9049783618.89
553Triglycerides in very small VLDL (UKB data field 23522)GCST9026961918.85
554PCDH17/PTPRM ratioGCST9031560318.80
555Linoleic acid to total fatty acids percentageGCST9050233318.80
556Non-HDL cholesterol levelsGCST9023966918.79
557IDP dMRI TBSS FA Middle cerebellar peduncleGCST9000387718.70
558CD40LG/EREG ratioGCST9031382018.69
559BCR/CLIP2 ratioGCST9031348618.69
560aparc-Desikan rh area lateraloccipitalGCST9000311718.66
561Aneurysm of iliac artery (PheCode 442.2)GCST9047599518.63
562OsteomyelitisFING0000091118.63
563Glucosamine medicationFING0000058418.60
564Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T255ECGU00025518.53
565Phospholipids in large VLDLGCST9049824318.53
566Saturated fatty acids to total fatty acids percentage (UKB data field 23455)GCST9026955218.51
567NOTCH1/TIE1 ratioGCST9031554618.46
568Total cholesterol levelsGCST9001875418.45
569CELA3A/CPA1 ratioGCST9031400918.42
570Autorefraction - 3mm cylindrical power (left) | EyesightUKBB0000006218.41
571HDL cholesterol levelsGCST9049734018.39
572AGRP/CCN1 ratioGCST9031320218.39
573DNAJB1 levelsGCST9046901218.38
574Ectopic pregnancyFING0000048718.37
575GALNT10/TNFSF12 ratioGCST9031491618.36
576AXIN1/IKBKG ratioGCST9031340918.35
577Blood cell traits latent factor 4 (red cell)GCST9055924618.34
578Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+NH4]1+ levelsGCST9006027318.30
579Parental longevity (both parents in top 10%)GCST00669818.30
580Triglycerides to total lipids ratio in medium VLDLGCST9009292718.28
581IDP dMRI TBSS ICVF External capsule LGCST9000436018.27
582TriglyceridesGCST00221618.26
583TARBP2/TDRKH ratioGCST9031590218.26
584CTSC levelsGCST9046890918.21
585EGF/MGLL ratioGCST9031461018.20
586Docosahexaenoic acid levelsGCST9049725618.18
587Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050241018.17
588ESAM/TGFB1 ratioGCST9031471818.17
589Omega-3 fatty acids to total fatty acids percentageGCST9049915518.15
590Medication use (HMG CoA reductase inhibitors)GCST9001876918.13
591EFNA4/LAYN ratioGCST9031460218.12
592LEFTY2 levelsGCST9046975218.10
593Omega-6 fatty acids to total fatty acids percentageGCST9050252818.09
594Triglycerides to Total Lipids in Large HDL percentageGCST9049790618.06
595VPS37A levelsGCST9047104618.03
596FADD/PLIN3 ratioGCST9031477218.03
597Free Cholesterol to Total Lipids in Large HDL percentageGCST9049779018.02
598Total lipids in HDL (UKB data field 23426)GCST9026952317.99
599Cholesterol to total lipids ratio in small LDLGCST9009295717.97
600CCL18/TFPI ratioGCST9031369117.92
601BCAM levelsGCST9046842517.91
602Free cholesterol in small LDLGCST9049961717.87
603Free cholesterol levels in medium HDLGCST9009289617.84
604QC rfMRI-to-T1 linear alignment discrepancyGCST9000635317.84
605Concentration of very large HDL particlesGCST9009301117.83
606Phospholipids in large LDLGCST9049805317.82
607Total lipids in medium HDL (UKB data field 23566)GCST9026966317.80
608Saturated fatty acids to total fatty acids percentageGCST9050268417.78
609Polyunsaturated fatty acids to total fatty acids percentageGCST9050263217.76
610HDL x anxiety interaction (2df test)GCST9057066517.75
611Triglycerides to Total Lipids in Very Large HDL percentageGCST9050050617.75
612Saturated fatty acids levelsGCST9049995317.74
613Sphingomyelin_36:2_[M+H]1+ levelsGCST9006026317.72
614Triglycerides in very large HDL (UKB data field 23557)GCST9026965417.70
615CREG1/NAAA ratioGCST9031425017.70
616SHMT1 levelsGCST9047062717.70
617Phospholipids in HDL (UKB data field 23414)GCST9026951117.68
618Total lipids in very large HDLGCST9050042317.66
619GLB1/PCSK9 ratioGCST9031493317.66
620PSME2/RBKS ratioGCST9031573717.66
621CD80 levelsGCST9046865017.64
622DTI TBSS MD Sagittal stratum LGCST9038460317.63
623Cholelithiasis and cholecystitis | digestiveUKBB0000013317.60
624SUGT1/TBL1X ratioGCST9031589717.58
625FAP levelsGCST9046918917.53
626Cholesterol to total lipids ratio in very large VLDLGCST9009301717.44
627Right-hemisphere control network to putamen white-matter structural connectivityGCST9030283817.40
628Phospholipids in very large HDL (UKB data field 23553)GCST9026965017.38
629CCDC80/CCL27 ratioGCST9031366917.37
630Total lipids in large HDL (UKB data field 23559)GCST9026965617.31
631CD69/SCARF1 ratioGCST9031388517.31
632Total lipid levels in medium HDLGCST9009289817.29
633APRT/MIF ratioGCST9031333617.29
634TNXB levelsGCST9047093017.27
635Cholesterol in Large LDLGCST9049792317.26
636Cholesteryl esters to total lipids ratio in very large VLDLGCST9009301917.26
637Hearing difficultyGCST9024577417.26
638Phosphatidylcholine (34:5) levelsGCST9002428617.24
639Ratio of omega-6 fatty acids to total fatty acidsGCST9009293517.23
640Cholesterol in Small VLDLGCST9049975017.17
641Free cholesterol to total lipids ratio in large HDLGCST9009284917.16
642Phospholipids in very small VLDLGCST9050085117.15
643DCTN6/TDRKH ratioGCST9031443617.14
644Illnesses of siblings - Heart disease | Family historyUKBB0000035117.13
645BCAM/NOTCH1 ratioGCST9031347417.12
646Triglyceride to HDL cholesterol ratioGCST9029595117.12
647Isoleucine levelsGCST9009284317.04
648Sphingomyelin_42:2_[M+OAc]1- levelsGCST9006050717.02
649Phospholipid levels in HDLGCST9009282717.02
650Omega-6 fatty acids to total fatty acids percentageGCST9050252916.99
651Saturated fatty acids to total fatty acids percentageGCST9050269716.97
652aseg rh intensity Lateral-VentricleGCST9000377816.92
653CHMP1A levelsGCST9046874616.88
654Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)GCST9026957916.85
655Abdominal aortic aneurysm (PheCode 442.11)GCST9047599416.84
656ESAM/THPO ratioGCST9031471916.82
657Average diameter for LDL particlesGCST9009288916.81
658BCL2L15 levelsGCST9046843116.81
659IDP dMRI TBSS L3 External capsule LGCST9000420416.80
660Total phospholipid levels in lipoprotein particlesGCST9050011016.79
661Total Phosphatidylcholine levelsGCST9002520416.75
662Neuroticism score | Mental healthUKBB0000049616.75
663Phosphatidylcholine_36:5_[M+H]1+/Phosphatidylethanolamine_39:5_[M+H]1+/Phosphatidate_41:6_[M+NH4]1+ levelsGCST9006034516.73
664aparc-a2009s lh volume G-precentralGCST9000295316.72
665Omega-3 fatty acid levelsGCST9050242416.71
666Cholesteryl esters to total lipids ratio in very large HDLGCST9009300716.68
667Liver proton density fat fractionGCST9026735216.64
668Cholesteryl esters in large HDL (UKB data field 23562)GCST9026965916.63
669Coxarthrosis [arthrosis of hip] | ArthrosisUKBB0000015416.63
670Saturated fatty acids levelsGCST9050219216.62
671Cholesterol to total lipids ratio in medium VLDLGCST9009291716.61
672Lysophosphatidylcholine (22:6) [sn2] levelsGCST9002418516.60
673HippSubfield lh volume molecular-layer-HP-headGCST9000267716.55
674Colorectal cancerGCST9001858816.54
675Omega-3 fatty acid levelsGCST9050243616.53
676PLA2G1B/PRSS2 ratioGCST9031566516.52
677Triglycerides in HDLGCST9049746716.49
678SNCA levelsGCST9024025816.46
679Triacylglycerol (48:2) [NL-16:0] levelsGCST9002514316.44
680BA-exvivo lh thickness BA4aGCST9000351716.40
681JAM2/TNFRSF14 ratioGCST9031524016.39
682Docosahexaenoic acid levelsGCST9050225516.33
683Triacylglycerol_53:5_[M+NH4]1+ levelsGCST9006052016.33
684GALNT10/IGSF3 ratioGCST9031491416.32
685Polyunsaturated fatty acids to saturated fatty acids ratioGCST9050259316.31
686Cholesteryl esters to total lipids ratio in medium VLDLGCST9009291916.31
687LDL cholesterolGCST9001874116.31
688Haematocrit percentage (UKB data field 30030)GCST9046807316.29
689APP/VEGFC ratioGCST9031333316.27
690FrecklesGCST00609116.26
691CNTN3/NCS1 ratioGCST9031416516.23
692APCS levelsGCST9046832816.22
693PSG1 levelsGCST9047035316.18
694Chronic osteomyelitis (PheCode 710.12)GCST9047622316.12
695ITGA11 levelsGCST9046963316.10
696Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050255416.08
697Left-hemisphere salience/ventral attention network to right-hemisphere somatomotor network white-matter structural connectivityGCST9030271316.08
698CD109 levelsGCST9046859716.07
699Cholesteryl Esters in HDLGCST9049735716.06
700Cholesteryl esters to total lipids ratio in small HDLGCST9009294716.06
701Cholesteryl Esters in Medium VLDLGCST9049892816.04
702CTSF/NAAA ratioGCST9031431416.02
703Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T85ECGA00008516.02
704FKBP5/MITD1 ratioGCST9031484415.99
705AXL/IL18BP ratioGCST9031342015.99
706IDP dMRI ProbtrackX OD str rGCST9000447415.94
707LILRB2 levelsGCST9046977715.94
708Educational attainmentGCST00349615.88
709Omega-6 fatty acid levelsGCST9050209415.87
710Total lipid levels in HDLGCST9009282515.87
711Cholesterol levels in very large HDLGCST9009300415.87
712APOA1 levelsGCST9009280815.87
713Degree of unsaturationGCST9050222515.83
714Cholesterol in large HDL (UKB data field 23561)GCST9026965815.80
715HYOU1/TGFBR3 ratioGCST9031510515.78
716CRNN levelsGCST9046886915.78
717CD93/TNFRSF4 ratioGCST9031392215.74
718HSD11B1/SMPD1 ratioGCST9031508215.71
719ICAM1/SELE ratioGCST9031511615.68
720CTSO/IGF2R ratioGCST9031431715.67
721PLA2G10 levelsGCST9047024415.65
722Triglycerides in small LDLGCST9049972215.61
723Irritability | Mental healthUKBB0000038015.61
724Ratio of polyunsaturated fatty acids to monounsaturated fatty acidsGCST9009294015.60
725Cholesterol esters in very large HDLGCST9050035415.60
726BA-exvivo lh volume BA3aGCST9000283715.59
727QC dMRI-to-T1 linear alignment discrepancyGCST9000635115.56
728Concentration of medium HDL particlesGCST9009289915.56
729X-21829 levelsGCST9020058515.55
730IL6ST levelsGCST9046960315.55
731Concentration of large HDL particles (UKB data field 23558)GCST9026965515.55
732TTR levelsGCST9047098515.54
733SYT1 levelsGCST9047079415.52
734NHLRC3 levelsGCST9047004615.52
735Monounsaturated fatty acids to total fatty acids percentage (UKB data field 23454)GCST9026955115.51
736Omega-3 fatty acid levelsGCST9050242515.50
737Triglycerides to Total Lipids in Large VLDL percentageGCST9049828715.43
738IDP dMRI ProbtrackX MO str rGCST9000402415.43
739PON3 levelsGCST9047028715.42
740X-26109 levelsGCST9020067115.42
741SRC/STAT5B ratioGCST9031588215.42
742CLEC1A/TNFRSF1A ratioGCST9031408515.42
7433-Hydroxybutyrate levelsGCST9009281115.39
744ADGRG2 levelsGCST9046824115.36
745CLEC3B levelsGCST9046877015.35
746Cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23581)GCST9026967815.35
747Diseases of male genital organsFING0000042615.34
748Cholesterol levels in very small VLDLGCST9050071215.34
749Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050109115.32
750RWDD1/SUMF2 ratioGCST9031579515.32
751Triglycerides in very small VLDLGCST9050088515.31
752Total concentration of lipoprotein particlesGCST9050010315.31
753Red blood cell (erythrocyte) distribution width | Blood countUKBB0000074815.31
754Docosahexaenoic acid levelsGCST9049725215.30
755IDP dMRI TBSS MD External capsule RGCST9000405915.30
756KITLG levelsGCST9046969115.29
757ACVRL1/EFNA4 ratioGCST9031315615.22
758ITGB1/TFPI ratioGCST9031523115.16
759Cholesterol esters in very small VLDLGCST9050074915.14
760AOC3 levelsGCST9046832215.13
761Omega-6 fatty acids to omega-3 fatty acids ratioGCST9049919915.12
762DIABLO/VSIR ratioGCST9031447015.11
763ESAM/TNFRSF14 ratioGCST9031472015.10
764Docosahexaenoic acid levelsGCST9050224315.09
765Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484)GCST9026958115.09
766Myopia (PheCode 367.1)GCST9047588015.09
767Cholesteryl Esters in Small HDLGCST9049938215.09
768ERBIN/TBC1D23 ratioGCST9031469815.07
769Total lipid levels in large HDLGCST9009285015.06
770Triglyceride levels in medium LDLGCST9009291415.05
771Docosahexaenoic acid to total fatty acids percentageGCST9050226915.03
772Urine 5-acetylamino-6-amino-3-methyluracil levels in chronic kidney diseaseGCST9026467415.01
773Hearing difficulty and hearing difficulty with background noiseGCST9024576814.98
774Phosphatidylcholine-O_40:5_[M+H]1+/Phosphatidylcholine-P_40:4_[M+H]1+ levelsGCST9006042314.98
775Cholesteryl Esters to Total Lipids in Large HDL percentageGCST9049776814.97
776Triglyceride levels in chylomicrons and extremely large VLDLGCST9013263014.93
777ThalamNuclei lh volume CeMGCST9000272514.92
778Total cholesterol levels in HDLGCST9013268114.90
779IDP dMRI ProbtrackX FA str rGCST9000394914.84
780Triglyceride levels in LDLGCST9009289014.84
781Omega-6 fatty acids to omega-3 fatty acids ratioGCST9049919414.84
782Nonalcoholic fatty liver diseaseGCST9005478214.81
783Cholesteryl Esters to Total Lipids in Small HDL percentageGCST9049940614.80
784COMP/ICAM1 ratioGCST9031418914.76
785Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)GCST9026957814.74
786Triglycerides to Total Lipids in Medium HDL percentageGCST9049868214.73
787Urine 3-hydroxyindolin-2-one sulfate levels in chronic kidney diseaseGCST9026450814.72
788Cholesterol in Large HDLGCST9049770914.70
789STAMBP levelsGCST9047075614.66
790Glomerular filtration rate (cystatin C)GCST00337514.65
791Phosphatidylethanolamine (18:0_18:1) levelsGCST9002497714.63
792CRKL/FIS1 ratioGCST9031426614.63
793Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457)GCST9026955414.63
794LEPR levelsGCST9046975614.62
795Glycoprotein acetyls levelsGCST9009282114.61
796ESAM/VSIR ratioGCST9031472114.59
797Cholesteryl ester levels in large HDLGCST9009284614.58
798Plasma 3-hydroxyhexanoate levels in chronic kidney diseaseGCST9026449814.55
799HYOU1/THBD ratioGCST9031510614.53
800HDL x depression interaction (2df test)GCST9057066714.52
801aparc-a2009s rh area S-centralGCST9000341514.49
802Free cholesterol in large LDLGCST9049798114.47
803Hyperglyceridemia (PheCode 272.12)GCST9047572414.44
804LDL cholesterolGCST00222214.41
805Diacylglycerol (18:0_18:1) levelsGCST9002471414.40
806Chronic bronchitis (PheCode 496.2)GCST9047602914.40
807Cholesterol to Total Lipids in IDL percentageGCST9049751114.39
808GYS1/TIA1 ratioGCST9031500414.37
809LGALS8/TXNDC5 ratioGCST9031532114.37
810LYPD8 levelsGCST9046982914.36
811Triglycerides to total lipids in small HDL percentage (UKB data field 23648)GCST9026974514.36
812DTI TBSS MD Uncinate fasciculus RGCST9038461614.34
813HDL cholesterol | Blood biochemistryUKBB0000030614.33
814CD164 levelsGCST9046860214.32
815Total lipids in very small VLDLGCST9050081014.31
816Cholesteryl Esters in Large HDLGCST9049775114.30
817DTI TBSS L3 Retrolenticular part of internal capsule LGCST9038454514.30
818Trihexosylcermide (d18:1/18:0) levelsGCST9002473814.28
819Polyunsaturated fatty acid levelsGCST9050214014.27
820Multi-trait sex scoreGCST9027011814.25
821Hypertrophy of breast (Gynecomastia) (PheCode 612.2)GCST9047616314.23
822Triglycerides to Total Lipids in Very Large VLDL percentageGCST9050069214.23
823Cholesterol to Total Lipids in Large HDL percentageGCST9049773214.22
824TOMM20 levelsGCST9047093114.20
825ENTPD6 levelsGCST9046912214.19
826Total lipid levels in chylomicrons and extremely large VLDLGCST9050100214.17
827Cholesteryl esters in chylomicrons and extremely large VLDL (UKB data field 23485)GCST9026958214.14
828CELA3A/KIRREL2 ratioGCST9031401314.13
829Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)GCST9026958014.13
830HDL cholesterolGCST00222314.13
831DECR1/METAP1D ratioGCST9031444814.12
832Free cholesterol levels in large HDLGCST9009284814.10
833Polyunsaturated fatty acid levelsGCST9049926614.09
834Ascites (non malignant) (PheCode 572)GCST9047609014.09
835Concentration of large HDL particlesGCST9009285114.09
836Free cholesterol to total lipids in very small VLDL percentage (UKB data field 23607)GCST9026970414.07
837OPTC levelsGCST9047012814.07
838Cholesterol levels in large HDLGCST9009284414.05
839Triglycerides in small LDL (UKB data field 23550)GCST9026964714.04
840Acquired absence of organs, not elsewhere classified | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB0000000514.04
841Phospholipid levels in very large HDLGCST9013264214.04
842RAB10 levelsGCST9047040314.03
843Estradiol levelsGCST9002009114.02
844Benign lipomatous neoplasm of skin and subcutaneous tissue of trunkFING0000015014.00
845X-12063 levelsGCST9024368713.98
846Triglycerides in very small VLDLGCST9050087313.98
847CPE levelsGCST9046884113.98
848GRP levelsGCST9046940613.98
849Hippocampal subfield left CA3 volume (body)GCST9026794013.97
850IDP dMRI ProbtrackX ICVF cst rGCST9000438413.96
851Triglyceride levels in chylomicrons and extremely large VLDLGCST9009305013.94
852PON1 levelsGCST9047028513.94
853Triglycerides x anxiety interaction (2df test)GCST9057067713.93
854Cholesteryl Esters to Total Lipids in Small HDL percentageGCST9049940313.92
855Phospholipids to total lipids ratio in large HDLGCST9009285313.90
856REST UKBBICA NET100 1287GCST9038714113.90
857Cholesterol to total lipids ratio in small VLDLGCST9009296913.90
858Phospholipids to Total Lipids in Very Small VLDL percentageGCST9050085613.90
859High density lipoprotein cholesterol levelsGCST9027863513.90
860CERT/PRTFDC1 ratioGCST9031402913.87
861Lipoma of skin and subcutaneous tissue (PheCode 214.1)GCST9047561913.86
862DBI levelsGCST9046894913.86
863Free cholesterol in small VLDLGCST9049981713.85
864Chronic Kidney Disease, Stage IV (PheCode 585.34)GCST9047613013.85
865QC tfMRI-to-T1 linear alignment discrepancyGCST9000635413.84
866CES3 levelsGCST9046872013.84
867Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050214713.80
868CD69/SNAP29 ratioGCST9031388713.78
869Phosphoglycerides levelsGCST9049926513.78
870ALB levelsGCST9001872513.77
871LSP1/NADK ratioGCST9031533113.77
872Hearing difficulty with background noiseGCST9024577513.77
873Cholesteryl ester levels in very large HDLGCST9009300613.76
874Free cholesterol to total lipids ratio in small LDLGCST9009296113.75
875aseg global volume BrainSegGCST9000259013.74
876Cholesteryl Esters to Total Lipids in Very Large HDL percentageGCST9050037313.74
877Triglycerides in small VLDLGCST9049991513.74
878CNTN5/ROBO2 ratioGCST9031416613.74
879ERP44/SUMF2 ratioGCST9031471013.73
880Free cholesterol in large HDL (UKB data field 23563)GCST9026966013.73
881DTI TBSS MD Retrolenticular part of internal capsule LGCST9038459313.72
882Basophil count varianceGCST9056568213.71
883Cholesterol levels in very small VLDLGCST9050070013.71
884Brain glioblastoma, excluding all cancers (controls excluding all cancers)FING0000022513.70
885Nephritis and nephropathy without mention of glomerulonephritis (PheCode 580.3)GCST9047611513.68
886PRKAR1A levelsGCST9047032613.65
887X-04499--3,4-dihydroxybutyrate levelsGCST9024349713.64
8881-stearoyl-2-linoleoyl-GPI (18:0/18:2) levelsGCST9020006713.64
889EPO/TFRC ratioGCST9031468413.63
890Concentration of HDL particles (UKB data field 23430)GCST9026952713.63
891Total cholines levelsGCST9049718313.62
892AXIN1/GOPC ratioGCST9031340713.62
893Cholesteryl ester_14:0_[M+NH4]1+ levelsGCST9006019713.62
894Familial combined hyperlipidemia defined by Dutch criteriaGCST9010400513.59
895Sleep apnea (MTAG)GCST9026736213.58
896EPHB4/ESAM ratioGCST9031467913.57
897Triglyceride to HDL cholesterol ratioGCST9029594913.56
898Cyst of kidney, acquired (PheCode 586.2)GCST9047613313.55
899IDP dMRI TBSS OD Posterior limb of internal capsule RGCST9000442013.54
900STAMBP/WWP2 ratioGCST9031588813.51
901Cholelithiasis | Disorders of gallbladder, biliary tract and pancreasUKBB0000013213.49
902Cholesteryl esters to total lipids ratio in very small VLDLGCST9009303113.47
903FAM171B levelsGCST9046918313.46
904RNASEH2A levelsGCST9047048013.46
905Hypertrophy of breastFING0000064413.44
906Free Cholesterol to Total Lipids in Very Large HDL percentageGCST9050039713.44
907CST6 levelsGCST9046889613.42
908IDP dMRI ProbtrackX MO str lGCST9000402313.41
909ERN1 levelsGCST9046914813.40
910aparc-a2009s rh area G+S-occipital-infGCST9000337213.40
911CD63/CLEC1B ratioGCST9031386313.40
912Marzipan likingGCST9009479713.38
913PLIN3/TYMP ratioGCST9031567813.34
914Phospholipids in small VLDLGCST9049987113.33
915Free cholesterol to total lipids ratio in small HDLGCST9009294913.32
916HyperlipidemiaGCST9009099413.32
917Free cholesterol in chylomicrons and extremely large VLDL (UKB data field 23486)GCST9026958313.30
918Cholesterol in medium HDL (UKB data field 23568)GCST9026966513.27
919APOA1 levelsGCST9046833113.26
920VegetarianismGCST9042883813.25
921IDP dMRI TBSS L2 Middle cerebellar peduncleGCST9000412313.24
922T1 FreeSurfer aseg Left-choroid-plexusGCST9038415613.24
923Dihexosylceramide (d18:1/22:0) levelsGCST9002534813.24
924Degree of unsaturationGCST9050017513.24
925Triglycerides in small HDL (UKB data field 23578)GCST9026967513.24
926OtosclerosisGCST9012957513.23
927Triglycerides in small VLDL (UKB data field 23515)GCST9026961213.21
928ENG/NOTCH1 ratioGCST9031464813.18
929Free cholesterol in medium LDLGCST9049876713.17
930Phospholipids to total lipids ratio in small LDLGCST9009296513.13
931Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levelsGCST9006055713.13
932aparc-DKTatlas lh volume caudalanteriorcingulateGCST9000286313.12
933DAB2/ZBTB16 ratioGCST9031437013.12
934PCDH17/SEMA7A ratioGCST9031560513.10
935S100A11 levelsGCST9047051213.08
936Cholesterol to Total Lipids in Small HDL percentageGCST9049936913.07
937PPP1R2/TMSB10 ratioGCST9031572113.04
938Stable angina pectorisGCST9001869513.02
939Red cell distribution widthGCST9002598813.02
940Phospholipids in medium HDLGCST9049863513.01
941CRHBP/TREM2 ratioGCST9031426013.00
942Cigarettes smoked per day (MTAG)GCST9017915113.00
943CSF1/LTBR ratioGCST9031428713.00
944Free cholesterol to total lipids ratio in medium HDLGCST9009289712.99
945Free cholesterol to total lipids ratio in small VLDLGCST9009297312.99
946APOB/APOA1 ratioGCST9026953812.99
947IDP dMRI ProbtrackX MD ar lGCST9000421912.99
948DNAJB1/PPME1 ratioGCST9031451012.96
949Triglycerides in very large VLDL (UKB data field 23494)GCST9026959112.95
950CLIP2/DNAJA2 ratioGCST9031412712.92
951Total lipids in very large HDL (UKB data field 23552)GCST9026964912.91
952aseg global volume SupraTentorialGCST9000259512.90
953FGR levelsGCST9046923612.89
954Omega-3 fatty acids to total fatty acids percentageGCST9049916312.87
955SBSN levelsGCST9047053112.84
956ADGRG2/NRCAM ratioGCST9031318612.83
957Average diameter for VLDL particlesGCST9050029012.83
958Omega-6 fatty acids levelsGCST9049917012.80
959STC2 levelsGCST9047076212.78
960Polyunsaturated fatty acid levelsGCST9049927112.78
961Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T96ECGU00009612.76
962Worrier / anxious feelings | Mental healthUKBB0000092112.75
963X-23641 levelsGCST9020060312.75
964DECR1/MAP2K6 ratioGCST9031444712.74
965aparc-Desikan lh thickness postcentralGCST9000346612.74
966ENDOU levelsGCST9046910712.73
967ICAM2/SELE ratioGCST9031512012.73
968ENG levelsGCST9046910812.72
969Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [LDH] (PheCode 573.6)GCST9047609412.69
970Retinal detachments and defects (PheCode 361)GCST9047584512.69
971Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T135ECGA00013512.67
972Cholesteryl Esters in IDLGCST9049752512.67
973Hands-free device/speakerphone use with mobile phone in last 3 month | Electronic device useUKBB0000030412.64
974Red blood cell erythrocyte distribution width (UKB data field 30070)GCST9046809912.64
975PVR levelsGCST9047039412.63
976Free cholesterol to total lipids ratio in medium LDLGCST9009290912.63
977ANGPT1/SERPINE1 ratioGCST9031326912.63
978APOE levelsGCST9046833812.60
979Free cholesterol levels in HDLGCST9009282412.60
980Smoking dependencyFING0000131512.60
981Cheese intake | DietUKBB0000012712.58
982Triglycerides in large HDLGCST9049788812.57
983aparc-Desikan lh volume precentralGCST9000279112.57
984Phospholipid levels in small HDLGCST9009295212.56
985IDP dMRI ProbtrackX MD cst lGCST9000422712.55
986Triglycerides to Total Lipids in Very Small VLDL percentageGCST9050090012.55
987Phospholipids in medium HDLGCST9049864112.55
988Triglycerides in medium HDLGCST9049866712.54
989IDP dMRI TBSS L2 Corticospinal tract RGCST9000412912.51
990Saturated fatty acids levelsGCST9050218612.50
991Androstenediol (3alpha, 17alpha) monosulfate (3) levelsGCST9019985612.49
992Triglycerides in HDL (UKB data field 23410)GCST9026950712.49
993Phospholipids in medium LDLGCST9049883212.48
994Phospholipids to total lipids in large HDL percentage (UKB data field 23634)GCST9026973112.47
995BCAN/CD200 ratioGCST9031347712.47
996Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)GCST9026973812.46
997Cholesteryl Esters in Large LDLGCST9049795512.44
998aparc-DKTatlas lh thickness postcentralGCST9000356012.43
999APOB/APOA1 ratioGCST9049715612.40
1000LTBP2 levelsGCST9046981412.39